Ontex: Transparency Declaration Notification
Disclosure made according to the requirements of Article 14 of the law of 2 May 2007
AALST-EREMBODEGEM, Belgium--(BUSINESS WIRE)-- Regulatory News:
Ontex Group NV (BSE: ONTEX) (“Ontex”) discloses the notification of significant shareholdings that it has received according to the Belgian Law of 2 May 2007 on the disclosure of significant shareholdings in listed companies.
On April 21, 2020, Morgan Stanley notified Ontex that as a result of the disposal of voting securities or voting rights, it has crossed below the threshold of 5.00% of voting securities in Ontex on April 15, 2020.
According to its obligation Ontex publishes the content of the notifications that it has received.
Reason for the notification: Acquisition or disposal of voting securities or voting right and acquisition or disposal of financial instruments that are treated as voting securities.
Notification by: A parent undertaking or a controlling person
Persons subject to the notification requirement:
Name |
Address (for legal entities) |
Morgan Stanley |
c/o The Corporation Trust Company (DE), Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, USA |
Date of Notification: April 21, 2020
Date Threshold Crossed: April 15, 2020
Threshold Crossed: 5.00%
Denominator on the date of notification: 82,347,218 shares
Voting rights and assimilated financial instruments:
Notification of April 21, 2020:
(A) Voting rights |
Previous
|
After the transaction |
|||
# voting
|
# voting
|
% of voting
|
|||
Holders of voting rights |
|
Linked to securities |
Not linked to securities |
Linked to securities |
Not linked to securities |
Morgan Stanley |
0 |
|
|
|
|
Morgan Stanley & Co. International plc |
987,923 |
|
|
|
|
Morgan Stanley Europe SE |
395,769 |
|
|
|
|
Total |
1,383,692 |
|
|
|
|
(B) Equivalent financial instruments |
After the transaction |
|||||
Holders of equivalent
|
Type of financial instrument |
Expiration date |
Exercise period or date |
# of voting rights that may be acquired if the instrument is exercised |
% of voting rights |
Settlement |
TOTAL |
|
|
|
|
|
|
|
# voting rights |
% of voting rights |
TOTAL (A + B) |
|
|
Full chain of controlled undertakings through which the holding is effectively held
Chain of controlled undertakings for Morgan Stanley & Co. LLC
• Morgan Stanley & Co. LLC, c/o The Corporation Trust Company (DE), Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, USA. is a direct holder and is a subsidiary of Morgan Stanley Domestic Holdings, Inc.
• Morgan Stanley Domestic Holdings, Inc., c/o The Corporation Trust Company (DE), Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, USA. is an indirect holder and is a subsidiary of Morgan Stanley Capital Management, LLC
• Morgan Stanley Capital Management, LLC, c/o The Corporation Trust Company (DE), Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, USA. is an indirect holder and is a subsidiary of the beneficial owner, Morgan Stanley
Chain of controlled undertakings for Morgan Stanley & Co. International plc
• Morgan Stanley & Co. International plc, Legal & Compliance Department, 25 Cabot Square, Canary Wharf, London, E14 4QA, UNITED KINGDOM. is a direct holder and is a subsidiary of Morgan Stanley Investments (UK)
• Morgan Stanley Investments (UK), 20 Bank Street, Canary Wharf, London, E14 4AD, UNITED KINGDOM. is an indirect holder and is a subsidiary of Morgan Stanley International Limited
• Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London, E14 4QA, UNITED KINGDOM. is an indirect holder and is a subsidiary of Morgan Stanley International Holdings Inc.
• Morgan Stanley International Holdings Inc., c/o The Corporation Trust Company (DE), Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, USA. is an indirect holder and is a subsidiary of the beneficial owner, Morgan Stanley
Chain of controlled undertakings for Morgan Stanley Europe SE
• Morgan Stanley Europe SE, Grosse Gallusstrasse 18, Frankfurt am Main, 60312, Germany. is a direct holder and is a subsidiary of Morgan Stanley Europe Holding SE
• Morgan Stanley Europe Holding SE, Grosse Gallusstrasse 18, Frankfurt am Main, 60312, Germany. is an indirect holder and is a subsidiary of Morgan Stanley International Limited
• Morgan Stanley International Limited, 25 Cabot Square, Canary Wharf, London, E14 4QA, UNITED KINGDOM. is an indirect holder and is a subsidiary of Morgan Stanley International Holdings Inc.
• Morgan Stanley International Holdings Inc., c/o The Corporation Trust Company (DE), Corporation Trust Center, 1209 Orange Street, Wilmington, Delaware, 19801, USA. is an indirect holder and is a subsidiary of the beneficial owner, Morgan Stanley
Morgan Stanley is not a controlled entity.
Additional information
Morgan Stanley's total holding in Ontex has fallen below the 5% threshold and as such, the trading book exemption has been applied to its remaining holding of 4.39% in accordance with Art. 10 §4 of the Law.
Notifications of significant shareholdings to be made according to the Law of 2 May 2007 should be sent to: [email protected]
This notification will be posted on: http://www.ontexglobal.com/press-room
About Ontex
Ontex is a leading international provider of personal hygiene solutions, with expertise in baby care, feminine care and adult care. Ontex’s innovative products are distributed in more than 110 countries through Ontex brands such as BBTips, BioBaby, Pompom, Bigfral, Canbebe, Canped, ID and Serenity, as well as leading retailer brands.
Employing some 10,000 passionate people all over the world, Ontex has a presence in 21 countries, with its headquarters in Aalst, Belgium. Ontex is listed on Euronext Brussels and is part of the Bel Mid®. To keep up with the latest news, visit www.ontex.com or follow us on LinkedIn, Facebook, Instagram and YouTube.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200426005038/en/
INVESTOR ENQUIRIES
Philip Ludwig
+32 53 333 730
[email protected]
PRESS ENQUIRIES
Gaëlle Vilatte
+32 53 333 708
[email protected]
Source: Ontex Group NV
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type 1 Diabetes
- Seven Ways to Get Featured on Yahoo Finance in Twenty Twenty Six
- Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Morgan Stanley, Definitive AgreementSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share